Clinical Trials Browser

OTHER × Has results × tipifarnib × Clear all

NCT03496766 2025-03-05

Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS

Phase 2 Terminated

9 enrolled 22 charts

Carcinoma, Non-Small-Cell Lung

NCT00050986 2020-09-22

Phase I/II Evaluation of Temozolomide and ZARNESTRA (R115777) for Recurrent and Progressive Glioblastoma Multiforme

Phase 1/2 Completed

55 enrolled 6 charts

Brain Neoplasms, Central Nervous System Diseases, Glioblastoma